跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINO SOLUTION FOR I.V INFUSION 20MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
IRINO SOLUTION FOR I.V INFUSION 20MG/ML
Approved
THERAPEUTIC
IRINO SOLUTION FOR I.V INFUSION 20MG/ML
TTY BIOPHARM COMPANY LIMITED (TAIWAN)
🇸🇬 Health Sciences Authority
Approval Date
Jun 21, 2013
Approval ID
acf49583c7b0b836
Company
TTY BIOPHARM COMPANY LIMITED (TAIWAN)
Type
Therapeutic
Approval Details
Approval Id
acf49583c7b0b836
Drug Name
IRINO SOLUTION FOR I.V INFUSION 20MG/ML
Product Name
IRINO SOLUTION FOR I.V INFUSION 20MG/ML
Approval Number
SIN14373P
Approval Date
2013-06-21
Registrant
PHARM-D SINGAPORE PRIVATE LIMITED
Licence Holder
PHARM-D SINGAPORE PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01XX19
Atc Item Name
xl 01 xx 19
Pharma Manufacturer Name
PHARM-D SINGAPORE PRIVATE LIMITED
Company Detail Path
/organization/pharm-d-singapore-private-limited
Active Ingredients
Irinotecan hydrochloride trihydrate
20 mg/ml
Irinotecan hydrochloride trihydrate
20 mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 21, 2013
Approval ID
acf49583c7b0b836
Type
Therapeutic
Back to HSA Approvals